Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
5,501	66.05096	0	female	0	42	493	Coma	Coma	1	9	under $11k	94	146,193	null	null	33	white	24	45	0.148987	0.096985	7	0	0	no	null	null	dnr after sadm	1	120	48.5	125	18	36.09375	160	null	0.899902	1.799805	137	7.40918	85	19	2,560	null	0	adl>=4 (>=5 if sur)	0
5,502	52.98297	0	male	0	4	493	Lung Cancer	Cancer	0	18	>$50k	0	11,170	5,573.0039	4,493	12	white	17.398438	11	0.727905	0.455994	1	0	0	metastatic	0.9	0.8	no dnr	4	132	6.299805	110	11	36.39844	147.59375	3.099609	1.299805	4	128	7.319336	661	28	780	0	0	no(M2 and SIP pres)	0
5,503	52.01898	1	male	0	7	228	Lung Cancer	Cancer	1	15	$25-$50k	0	13,461	7,303.3203	4,927	10	white	3.299805	6	0.904907	0.780884	1	0	0	metastatic	0.9	0.8	no dnr	7	0	64.890625	0	0	32.89844	33	null	null	3.099609	132	7.149414	180	80	280	0	0	null	0
5,504	44.54999	0	male	0	8	493	CHF	COPD/CHF/Cirrhosis	2	12	$25-$50k	0	11,776	null	null	10	black	15.099609	11	0.937988	0.894897	1	0	0	no	0.85	0.75	no dnr	8	75	9.199219	60	12	36.79688	188.5625	null	null	3.799805	130	7.479492	220	72	1,240	0	0	no(M2 and SIP pres)	0
5,505	63.88797	1	female	1	7	7	Cirrhosis	COPD/CHF/Cirrhosis	3	null	null	26	94,398	null	null	36	white	38.398438	65	0.096985	0.016998	14	0	0	no	0	0	dnr after sadm	6	72	7.5	110	26	36.5	361.875	3.299805	0.599976	0.399963	140	7.479492	126	1	2,675	null	null	<2 mo. follow-up	2.902832
5,506	66.56799	1	female	0	19	45	MOSF w/Malig	ARF/MOSF	1	16	>$50k	0	95,765	56,222.1875	64,797	22.666656	white	36.796875	63	0.231995	0.131989	23	0	0	yes	0.6	0.3	no dnr	19	57	5.199219	65	20	35.89844	null	null	2.599609	1.199951	122	null	64	22	4,290	null	1	<2 mo. follow-up	1
5,507	59.047	0	female	0	17	490	COPD	COPD/CHF/Cirrhosis	2	8	$25-$50k	0	35,298	23,559.5312	22,886	19	white	24.296875	27	0.845947	0.746948	1	0	0	no	0.6	0.5	no dnr	17	114	5.399414	69	24	36.5	324	3.299805	1.899902	1.5	141	7.529297	93	27	1,975	2	2	adl>=4 (>=5 if sur)	2
5,508	39.90399	0	female	0	55	490	MOSF w/Malig	ARF/MOSF	1	null	null	44	210,813	null	null	36.5	white	43	74	0.021999	0.004999	2	0	0	metastatic	0.1	0.02	dnr after sadm	2	105	25.199219	115	32	37.89844	97.95312	2.599609	0.5	1.5	147	7.419922	153	33	1,930	null	null	null	2.974121
5,509	63.82999	0	male	0	7	490	CHF	COPD/CHF/Cirrhosis	2	14	$25-$50k	0	15,924	null	null	10.5	white	11.099609	13	0.931885	0.884888	1	0	0	no	0.9	0.75	no dnr	7	70	36.195313	125	36	38.39844	137.75	2.599609	2.199707	2	158	7.459961	203	77	2,790	1	1	no(M2 and SIP pres)	1
5,510	67.25	0	male	0	8	488	COPD	COPD/CHF/Cirrhosis	1	16	$11-$25k	0	12,425	7,684.7969	7,854	13	white	21.699219	38	0.834961	0.72998	1	0	0	no	0.8	0.8	no dnr	8	106	10.5	119	28	37.89844	null	null	null	0.5	145	null	117	4	1,200	2	0	no(M2 and SIP pres)	0
5,511	66.12195	1	female	1	27	27	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	null	0	177,754	null	null	34.5	white	31	60	0.584961	0.474976	16	0	0	no	null	null	dnr after sadm	24	105	5.899414	110	32	36.69531	182.5	null	1.899902	0.699951	144	7.40918	373	20	3,795	null	0	<2 mo. follow-up	0
5,512	59.96698	1	male	1	7	7	CHF	COPD/CHF/Cirrhosis	4	12	under $11k	0	8,896	6,078.3438	6,487	17.5	white	18.097656	24	0.891968	0.819946	1	1	0	no	0.7	0.5	dnr after sadm	3	48	20.296875	225	26	36.69531	262.8125	2.099609	47	2.299805	128	7.429688	46	47	2,305	null	0	<2 mo. follow-up	0
5,513	64.28497	0	male	0	11	487	ARF/MOSF w/Sepsis	ARF/MOSF	0	7	under $11k	0	49,466	27,233.4844	30,352	25	black	18.699219	21	0.85498	0.804932	3	0	0	no	0.75	0.7	no dnr	11	52	13.699219	135	12	38.39844	142	null	7.799805	0.899902	150	7.549805	226	22	1,535	0	1	no(M2 and SIP pres)	1
5,514	61.50299	1	male	1	4	4	CHF	COPD/CHF/Cirrhosis	4	12	$25-$50k	0	11,292	null	null	15	white	71.1875	95	0	0	1	0	0	metastatic	0.1	0.3	dnr after sadm	1	62	10.199219	125	26	40.29688	228.5625	null	null	9.699219	139	7.319336	327	64	225	null	5	<2 mo. follow-up	5
5,515	71.737	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	under $11k	0	33,091	null	null	47	black	41.09375	81	0.327942	0.212982	3	1	0	no	0.65	0.6	dnr after sadm	3	95	4.599609	72	20	37.59375	null	3.299805	0.699951	0.899902	139	null	93	6	null	null	7	<2 mo. follow-up	7
5,516	71.19196	0	female	0	30	486	COPD	COPD/CHF/Cirrhosis	1	12	>$50k	0	61,413	null	null	13.25	white	23.699219	38	0.784912	0.654907	1	0	0	no	0.7	0.7	dnr after sadm	5	58	15.5	105	8	39.09375	227.5	null	4.699219	1.5	156	7.519531	49	50	2,365	0	null	null	0.494751
5,517	69.87799	1	male	0	11	166	ARF/MOSF w/Sepsis	ARF/MOSF	3	3	under $11k	9	27,756	null	null	18	white	24.296875	36	0.759888	0.682983	1	0	0	no	0.5	0.5	no dnr	11	78	10.298828	75	6	36.39844	250	1.599854	null	3	148	7.40918	105	52	1,680	0	0	no(M2 and SIP pres)	0
5,518	78.85596	1	female	0	77	89	ARF/MOSF w/Sepsis	ARF/MOSF	0	7	under $11k	41	478,649	null	null	32.75	white	23.597656	43	0.488953	0.370972	46	0	0	no	0.3	0.3	dnr after sadm	68	128	12.5	75	44	38.5	371.625	null	null	1.099854	145	7.329102	387	34	1,840	null	0	Coma or Intub	0
5,519	45.60397	0	female	0	10	484	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$25-$50k	0	22,584	null	null	22.5	white	19.796875	16	0.900879	0.86499	1	0	0	no	0.9	0.9	no dnr	10	111	10	105	36	38.29688	384	null	1.5	0.699951	135	7.359375	185	8	2,950	null	0	null	0
5,520	48.91998	1	male	1	58	58	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	>$50k	0	482,255	null	null	47.25	white	32.195313	59	0.621948	0.517944	5	0	0	yes	0.8	0.8	no dnr	58	135	6.5	65	12	36.29688	326.625	null	null	0.799927	144	7.379883	93	5	2,425	1	null	<2 mo. follow-up	1.166748
5,521	66.086	1	female	0	16	25	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	under $11k	61	112,648	null	null	36	white	35.296875	75	0.181976	0.093994	8	0	0	no	0.3	0.1	dnr after sadm	14	50	21.597656	135	31	39	147.5	null	0.699951	0.599976	142	7.429688	109	9	5,130	null	0	<2 mo. follow-up	0
5,522	70.09698	0	male	0	13	483	ARF/MOSF w/Sepsis	ARF/MOSF	0	9	under $11k	0	22,644	null	null	16	white	17.597656	17	0.858887	0.809937	2	0	0	no	0.9	0.9	no dnr	13	73	10.599609	65	7	36.5	182.5	null	null	1.399902	138	7.489258	94	19	2,010	6	0	adl>=4 (>=5 if sur)	0
5,523	68.67596	0	male	0	63	483	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$11-$25k	41	131,874	null	null	40.25	white	47.796875	81	0.026997	0.007	1	0	0	yes	0.6	0.6	no dnr	63	78	5.599609	70	22	36.19531	null	null	null	2.399902	134	null	79	42	1,910	null	5	adl>=4 (>=5 if sur)	5
5,524	36.78598	0	male	0	33	482	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	$25-$50k	0	97,532	null	null	28	black	26.796875	52	0.822998	0.762939	6	0	0	no	0.5	0.5	no dnr	33	117	22.5	125	40	35.59375	165	null	null	3	131	7.389648	128	125	2,160	3	6	no(M2 and SIP pres)	6
5,525	85.41296	1	female	0	9	126	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	$11-$25k	44	12,424	8,568.8906	10,477	18	white	25	23	0.523926	0.407959	1	0	1	no	0.6	0.6	dnr after sadm	1	143	13.298828	104	32	38.19531	490.4375	null	null	0.899902	133	7.379883	193	8	1,300	null	7	adl>=4 (>=5 if sur)	7
5,526	72.04395	0	male	0	25	482	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	null	0	100,393	null	null	23.25	white	23.699219	46	0.723999	0.638916	12	0	0	no	0.95	0.8	no dnr	25	140	26.597656	135	22	39.29688	75	null	null	1.599854	142	7.399414	97	25	1,005	0	0	no(M2 and SIP pres)	0
5,527	52.47598	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	94,485	null	null	58	white	42.695313	100	0.253967	0.149994	18	0	0	yes	0.4	0.35	dnr after sadm	4	125	12.898438	125	8	36.29688	172.5	null	null	1.899902	145	7.439453	286	19	4,385	null	null	<2 mo. follow-up	2.285645
5,528	59.34299	1	female	0	29	38	MOSF w/Malig	ARF/MOSF	2	18	null	0	null	null	null	36.75	white	35.695313	37	0.245972	0.142975	5	0	0	metastatic	0.8	0.3	null	null	77	0.399963	72	24	38.79688	null	null	0.899902	0.899902	138	null	107	4	null	null	2	<2 mo. follow-up	2
5,529	44.38898	0	female	0	114	479	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	9	256,454	null	null	42.75	white	19.898438	21	0.888916	0.849976	1	0	0	no	0.2	0.18	no dnr	114	58	8.898438	105	48	38.69531	231.40625	2.899902	0.899902	0.899902	131	7.479492	117	24	2,410	null	2	SIP>=30	2
5,530	65.82098	0	female	0	36	479	ARF/MOSF w/Sepsis	ARF/MOSF	0	17	$11-$25k	0	97,652	null	null	21.5	white	21.5	39	0.782959	0.711914	15	0	0	no	0.5	0.3	no dnr	36	75	1.5	104	20	36.5	466.625	2.099609	2.399902	0.799927	136	7.509766	143	8	1,050	null	7	no(M2 and SIP pres)	7
5,531	63.439	1	male	1	20	20	MOSF w/Malig	ARF/MOSF	2	null	null	44	101,509	null	null	35.666657	white	19.296875	36	0.632935	0.529907	1	0	0	yes	0.3	0.1	dnr after sadm	20	72	9.898438	75	28	36.19531	273.3125	4	1.199951	1.5	138	7.469727	90	40	2,790	null	0	<2 mo. follow-up	0
5,532	36.33398	0	female	0	5	478	Lung Cancer	Cancer	1	14	$25-$50k	0	11,640	5,957.5625	5,959	11	hispanic	15	13	0.800903	0.576904	1	0	0	metastatic	0.99	0.5	no dnr	5	135	14.298828	150	18	35.5	124	null	1.299805	1.599854	139	7.379883	344	64	960	0	0	no(M2 and SIP pres)	0
5,533	80.53894	1	male	1	17	17	ARF/MOSF w/Sepsis	ARF/MOSF	5	null	null	44	42,736	null	null	29.666656	white	26.199219	50	0.521973	0.405945	1	0	0	no	0.07	0.05	dnr after sadm	7	112	10.898438	75	28	38.69531	400	null	1.099854	0.799927	139	7.419922	138	12	2,095	null	null	<2 mo. follow-up	4.912109
5,534	40.84097	0	male	0	26	476	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	under $11k	0	82,428	null	null	21.25	white	29.097656	30	0.815918	0.754883	1	0	0	no	0.8	0.75	no dnr	26	83	11.798828	58	20	36.59375	null	null	6.099609	0.899902	138	null	93	11	1,000	1	1	SIP>=30	1
5,535	48.59097	0	male	0	15	477	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	$25-$50k	0	55,846	null	null	36	hispanic	34.695313	66	0.643921	0.542969	4	0	0	no	0.8	0.8	no dnr	15	118	10.398438	130	27	38.79688	185	null	24.898438	6.599609	138	7.429688	93	44	30	null	0	no(M2 and SIP pres)	0
5,536	71.00598	1	female	0	9	114	Lung Cancer	Cancer	3	12	under $11k	0	16,093	9,058	7,374	14.5	white	24.597656	7	0.506958	0.185974	1	1	0	metastatic	0.9	0.6	no dnr	9	99	9.898438	75	18	39	null	null	1	1.299805	140	null	119	26	1,200	4	6	adl>=4 (>=5 if sur)	6
5,537	62.92999	1	male	0	6	152	Lung Cancer	Cancer	1	17	>$50k	0	12,412	null	null	11	black	18.296875	10	0.685913	0.393982	1	0	0	metastatic	0.9	0.3	no dnr	6	118	17.597656	65	22	36.39844	null	3.199707	1	3.699707	135	null	60	87	2,525	0	0	no(M2 and SIP pres)	0
5,538	44.61298	1	male	0	6	200	Lung Cancer	Cancer	1	19	>$50k	0	12,011	null	null	7	white	15.298828	16	0.780884	0.541992	1	0	0	metastatic	0.8	0.6	no dnr	6	77	10.599609	95	28	38.29688	283.3125	2.099609	0.5	1.399902	137	7.419922	189	40	1,750	0	null	no(M2 and SIP pres)	0.494751
5,539	64.98596	0	female	0	13	475	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	under $11k	9	29,487	null	null	21	black	21	35	0.825928	0.766968	1	0	0	no	0.7	0.7	no dnr	13	33	19.199219	125	20	36.19531	230	1.599854	0.599976	4	136	7.439453	354	34	435	4	1	no(M2 and SIP pres)	1
5,540	68.92297	1	female	0	8	95	Lung Cancer	Cancer	2	12	under $11k	0	9,227	null	null	8.5	white	37.5	33	0.15097	0.008999	1	0	0	metastatic	0.7	0.5	no dnr	8	102	7.099609	120	38	35.39844	180	null	0.299988	0.5	142	7.489258	282	16	2,675	0	5	null	5
5,541	67.98596	1	male	0	9	10	Lung Cancer	Cancer	2	12	$11-$25k	0	8,297	null	null	10	white	14.5	14	0.747925	0.485962	1	0	0	metastatic	0.5	0.2	no dnr	9	122	11	115	8	38.09375	190	2.399902	1.299805	0.299988	138	7.619141	110	10	1,950	0	1	<2 mo. follow-up	1
5,542	37.97098	0	male	0	45	474	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	221,820	null	null	36.5	black	27.097656	23	0.81897	0.757935	5	0	0	no	0.6	0.6	dnr after sadm	18	133	4.5	110	28	38.5	323.75	null	1.5	0.699951	137	7.439453	66	10	2,835	null	4	no(M2 and SIP pres)	4
5,543	63.61099	0	female	0	12	474	COPD	COPD/CHF/Cirrhosis	2	null	null	26	33,089	null	null	27.5	white	23.597656	10	0.763916	0.625	1	0	0	no	0.75	0.7	no dnr	12	62	4.899414	105	20	35.39844	null	null	2.299805	1	137	null	89	18	4,600	null	0	no(M2 and SIP pres)	0
5,544	68.14496	1	male	0	5	110	Lung Cancer	Cancer	2	10	under $11k	9	4,951	3,143.1602	3,036	12	white	27.898438	23	0.375977	0.088989	1	0	0	metastatic	0.5	0.4	no dnr	5	58	7.099609	105	32	36.39844	96.65625	null	3.799805	1.099854	141	7.349609	106	34	1,555	null	0	no(M2 and SIP pres)	0
5,545	53.54099	1	female	0	9	52	ARF/MOSF w/Sepsis	ARF/MOSF	5	10	under $11k	0	18,073	null	null	20	white	20	27	0.882935	0.841919	1	0	0	no	0.5	0.5	no dnr	9	144	11.099609	155	9	35.79688	344	null	null	0.5	135	7.439453	115	25	815	5	null	<2 mo. follow-up	3.854981
5,546	51.38699	1	male	0	44	120	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	37	223,362	null	null	31	white	19.199219	30	0.714966	0.628906	17	0	0	yes	null	null	no dnr	44	138	16.398438	105	25	38.19531	147.5	null	1.299805	1.199951	144	7.429688	364	40	1,933	null	null	null	2.817871
5,547	41.41299	0	male	0	9	473	Colon Cancer	Cancer	1	13	$11-$25k	0	12,398	null	null	11	white	12.398438	9	0.897949	0.766968	1	0	0	metastatic	null	null	no dnr	9	72	10.199219	75	26	36.19531	197.9375	null	1.099854	4	135	7.389648	153	36	480	1	1	no(M2 and SIP pres)	1
5,548	40.54498	0	male	0	10	472	ARF/MOSF w/Sepsis	ARF/MOSF	1	9	null	9	25,414	null	null	21.5	black	23.898438	22	0.860962	0.81189	1	0	0	no	0.9	0.9	no dnr	10	161	26.699219	55	45	40.29688	260	null	null	0.699951	136	7.519531	159	20	3,180	0	null	SIP>=30	0.494751
5,549	74.81195	1	male	1	24	24	Coma	Coma	0	12	null	94	31,364	null	null	12.333328	white	15.898438	26	0.370972	0.297974	1	0	0	no	0.25	0.15	dnr after sadm	4	76	3.399902	68	16	36.5	null	3.299805	1	0.799927	138	null	101	4	3,850	null	0	<2 mo. follow-up	0
5,550	40.63199	0	male	0	54	472	ARF/MOSF w/Sepsis	ARF/MOSF	4	14	$25-$50k	9	278,369	null	null	27.75	white	28.296875	50	0.791992	0.723999	2	1	0	no	0.95	0.95	no dnr	54	99	8.199219	72	20	36.89844	null	4.399414	0.599976	1	143	null	90	7	5,000	null	0	adl>=4 (>=5 if sur)	0
5,551	59.90399	1	male	0	19	224	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	$11-$25k	0	null	null	null	16.333328	white	25.597656	25	0.685913	0.592896	11	0	0	yes	0.75	0.5	null	null	78	5.399414	72	20	36	null	null	0.899902	1	140	null	79	14	2,000	3	1	no(M2 and SIP pres)	1
5,552	62.59	0	male	0	7	471	CHF	COPD/CHF/Cirrhosis	2	6	under $11k	0	12,107	null	null	11.5	white	17.398438	32	0.891968	0.819946	1	1	0	no	null	null	no dnr	7	46	11	75	38	39.09375	120	2.699707	4.899414	1.5	150	7.469727	169	29	1,920	0	null	no(M2 and SIP pres)	0.494751
5,553	47.89297	1	male	1	18	18	Coma	Coma	4	10	under $11k	9	71,025	null	null	43	black	23	52	0.784912	0.743896	1	1	0	no	0.6	0.6	no dnr	18	48	0.099991	65	28	35.59375	376.1875	2	0.5	0.599976	136	7.509766	173	22	3,050	3	0	<2 mo. follow-up	0
5,554	19.21399	0	female	0	17	469	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	0	38,076	null	null	13.666664	white	33.695313	42	0.823975	0.764893	1	0	0	no	0.9	0.9	no dnr	17	108	6.599609	115	6	36.29688	171.40625	null	0.699951	0.699951	134	7.30957	125	22	2,270	null	1	no(M2 and SIP pres)	1
5,555	71.79498	1	male	1	7	7	Lung Cancer	Cancer	1	null	null	37	8,297	null	null	10	white	35.09375	48	0.065994	0.001	1	0	0	metastatic	0.1	0.05	dnr after sadm	1	65	0.099991	135	40	38.59375	81.32812	null	null	0.399963	146	7.5	200	23	2,615	null	null	<2 mo. follow-up	2.985352
5,556	78.33295	0	female	0	6	468	CHF	COPD/CHF/Cirrhosis	2	8	null	0	7,350	null	null	17	white	16.097656	26	0.863892	0.775879	1	0	0	no	0.9	0.75	no dnr	6	97	11.699219	74	24	35.89844	null	4.5	0.799927	1.099854	135	null	65	12	1,400	null	null	no(M2 and SIP pres)	1.986084
5,557	38.75198	0	female	0	7	468	CHF	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	15,121	null	null	6	other	16.699219	12	0.937988	0.894897	1	0	0	no	null	null	no dnr	7	62	6	124	26	36.09375	288	null	0.799927	1.199951	137	7.389648	137	30	1,010	6	null	SIP>=30	4.527344
5,558	44.43799	0	female	0	9	468	Cirrhosis	COPD/CHF/Cirrhosis	2	9	under $11k	0	9,608	null	null	7.5	black	30.796875	44	0.702881	0.540894	1	0	0	no	0.7	0.6	no dnr	9	58	12.5	65	10	36	364	3.399902	2.699707	2.099609	128	7.329102	147	59	419	0	0	no(M2 and SIP pres)	0
5,559	69.08698	1	female	0	15	70	COPD	COPD/CHF/Cirrhosis	2	9	$25-$50k	0	14,097	null	null	10.333328	white	17.199219	15	0.843994	0.743896	1	0	0	yes	null	null	no dnr	15	67	10.298828	69	24	36.29688	268	null	1.399902	1.199951	132	7.479492	64	23	2,850	null	null	adl>=4 (>=5 if sur)	2.939941
5,560	67.737	0	female	0	22	467	ARF/MOSF w/Sepsis	ARF/MOSF	3	7	under $11k	37	40,796	null	null	19.333328	black	24	49	0.681885	0.588989	1	1	0	no	0.5	0.4	no dnr	22	68	16.199219	75	40	38.79688	288.5625	null	null	1.399902	136	7.369141	125	12	3,475	null	7	adl>=4 (>=5 if sur)	7
5,561	53.771	0	female	0	29	467	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	110,603	null	null	22.75	white	27	37	0.802979	0.737915	1	0	0	no	null	null	no dnr	29	0	13	0	0	38	null	null	null	1.899902	133	null	295	133	350	null	1	no(M2 and SIP pres)	1
5,562	62.80899	1	male	0	18	125	Cirrhosis	COPD/CHF/Cirrhosis	3	18	under $11k	0	17,174	null	null	10.333328	white	17.898438	13	0.806885	0.687988	1	0	0	no	0.7	0.5	no dnr	18	45	15.898438	115	38	36	293.3125	null	1.599854	3.299805	145	7.319336	297	96	288	1	null	no(M2 and SIP pres)	1.166748
5,563	58.15997	1	male	1	8	8	Lung Cancer	Cancer	1	null	null	0	null	null	null	13	black	25.199219	38	0.533936	0.210999	1	0	0	metastatic	0.1	0.05	null	null	95	9.099609	160	26	36.09375	359.25	null	0.699951	0.699951	135	7.509766	137	17	7,160	null	null	<2 mo. follow-up	2.352051
5,564	54.34097	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	null	44	22,928	null	null	37	white	45.59375	91	0.106995	0.044998	4	0	0	no	null	null	dnr after sadm	3	108	18.898438	140	12	36.19531	322.1875	2.599609	0.599976	0.799927	141	7.439453	90	22	1,790	null	6	<2 mo. follow-up	6
5,565	78.44495	1	female	1	27	27	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	under $11k	0	137,050	null	null	19.75	white	20.796875	37	0.669922	0.573975	47	1	0	yes	0.5	0.5	dnr after sadm	27	65	6.599609	65	42	38.69531	280	null	0.899902	3.399902	136	7.40918	206	134	2,020	null	1	<2 mo. follow-up	1
5,566	64.78296	1	female	1	18	18	ARF/MOSF w/Sepsis	ARF/MOSF	3	6	under $11k	0	156,244	null	null	51	black	31.699219	50	0.60791	0.501953	6	1	0	no	null	null	dnr after sadm	17	107	10	65	28	36.09375	280	2.599609	0.299988	0.599976	135	7.40918	97	8	7,175	null	3	<2 mo. follow-up	3
5,567	68.99097	0	male	0	11	466	CHF	COPD/CHF/Cirrhosis	3	2	null	0	15,076	null	null	17	black	19.097656	35	0.859985	0.767944	1	0	0	no	null	null	no dnr	11	159	11.699219	50	10	36.79688	197.125	null	10.798828	1.399902	153	7.469727	155	42	1,595	0	0	no(M2 and SIP pres)	0
5,568	59.69098	1	male	0	9	175	Lung Cancer	Cancer	1	12	$25-$50k	0	12,240	null	null	12.5	white	12.599609	16	0.794922	0.565918	1	0	0	metastatic	0.9	0.8	no dnr	9	125	15.599609	125	40	38.39844	154.28125	1.799805	21	1.099854	142	7.389648	204	21	1,470	0	0	null	0
5,569	58.94897	1	male	0	5	231	Lung Cancer	Cancer	1	22	>$50k	0	11,230	null	null	13	white	14.298828	13	0.769897	0.522949	1	0	0	metastatic	0.8	0.6	no dnr	5	78	10.099609	75	25	36.09375	356.625	2.799805	0.699951	0.799927	141	7.40918	91	18	2,040	null	0	null	0
5,570	71.69897	1	female	1	21	21	CHF	COPD/CHF/Cirrhosis	5	11	under $11k	0	19,356	null	null	11	white	21.699219	25	0.820923	0.707886	1	1	0	no	0.7	0.6	dnr after sadm	6	45	14.099609	110	10	35.59375	87.14062	1.299805	1.699951	4.099609	143	7.449219	267	114	655	5	null	<2 mo. follow-up	3.854981
5,571	51.47198	1	male	1	12	12	Cirrhosis	COPD/CHF/Cirrhosis	3	14	>$50k	0	90,014	null	null	42	white	27.296875	31	0.720947	0.564941	1	0	0	no	null	null	dnr after sadm	12	68	15.199219	105	27	36.69531	225.6875	null	1.699951	7.399414	135	7.40918	139	79	169	null	1	<2 mo. follow-up	1
5,572	83.70197	1	female	1	3	3	Coma	Coma	0	null	null	100	44,537	null	null	36	white	64.5	103	0	0	11	0	0	no	null	null	dnr after sadm	3	122	15.298828	88	28	36.09375	148.3125	2.599609	0.5	0.599976	141	7.429688	134	18	975	null	null	<2 mo. follow-up	2.325684
5,573	56.70099	1	male	0	6	9	Lung Cancer	Cancer	2	11	null	9	8,106	null	null	8	white	24.199219	26	0.521973	0.199982	1	0	0	metastatic	0.3	0.1	dnr before sadm	0	58	15.398438	60	12	36	292	null	1.599854	1.099854	133	7.479492	99	42	1,640	null	3	<2 mo. follow-up	3
5,574	49.39899	0	male	0	18	462	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	>$50k	0	62,140	null	null	28.666656	white	21.398438	34	0.878906	0.836914	1	0	0	no	0.98	0.9	no dnr	18	43	25.296875	165	14	37.89844	150	1.5	1.399902	3.5	145	7.379883	227	40	145	null	0	no(M2 and SIP pres)	0
5,575	77.32794	0	female	0	15	462	ARF/MOSF w/Sepsis	ARF/MOSF	0	5	under $11k	9	48,687	null	null	19	black	26	58	0.659912	0.56189	3	0	0	no	0.3	0.2	no dnr	15	112	2.5	135	10	36.39844	133.3125	2.599609	null	1.299805	129	7.349609	154	41	2,235	null	1	no(M2 and SIP pres)	1
5,576	70.65796	1	male	0	39	268	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	91,132	null	null	23	black	23.398438	30	0.795898	0.72998	1	1	0	no	0.8	0.7	no dnr	39	63	13.699219	65	8	36.09375	373.3125	null	1	0.599976	138	7.449219	192	65	2,480	1	2	no(M2 and SIP pres)	2
5,577	51.01199	1	female	0	54	430	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	null	55	83,982	null	null	32.5	asian	22.796875	21	0.689941	0.596924	3	0	0	no	0.5	0.4	no dnr	54	122	18	105	24	36.5	213.3125	2.099609	1.299805	1.5	140	7.469727	145	45	2,900	null	0	null	0
5,578	39.67099	0	male	0	19	461	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	null	0	88,980	null	null	30	white	22.199219	57	0.862915	0.815918	8	1	0	no	0.5	0.5	no dnr	19	112	63.5	65	24	38.59375	185	3.299805	0.899902	1	148	7.469727	343	30	2,910	null	4	no(M2 and SIP pres)	4
5,579	77.07599	0	male	0	4	461	CHF	COPD/CHF/Cirrhosis	3	3	null	0	5,846	null	null	6	black	21.296875	28	0.804932	0.684937	1	1	0	no	null	null	no dnr	4	60	3.899902	68	20	37.09375	null	null	null	0.699951	139	null	88	4	4,400	null	0	no(M2 and SIP pres)	0
5,580	57.06998	1	female	0	26	29	Lung Cancer	Cancer	1	12	$25-$50k	0	40,442	null	null	11	white	17.398438	14	0.718994	0.441956	1	0	0	metastatic	null	null	no dnr	26	135	12.898438	115	36	38.19531	305	null	0.5	6.199219	139	7.369141	158	101	960	0	0	<2 mo. follow-up	0
5,581	54.20398	0	male	0	19	460	ARF/MOSF w/Sepsis	ARF/MOSF	2	6	$25-$50k	9	88,300	null	null	18.666656	white	22.597656	21	0.79895	0.731934	7	0	0	no	0.98	0.96	no dnr	19	102	33.09375	105	24	36.39844	196.65625	null	null	3.5	146	7.419922	122	35	4,140	null	0	no(M2 and SIP pres)	0
5,582	73.07599	1	male	0	7	220	Colon Cancer	Cancer	2	16	$11-$25k	0	13,001	null	null	10.5	white	21.898438	15	0.718994	0.441956	1	1	0	metastatic	0.9	0.8	no dnr	7	125	11.898438	120	10	35.39844	145	null	0.5	9	131	7.399414	223	99	170	0	0	no(M2 and SIP pres)	0
5,583	66.86694	0	male	0	15	459	ARF/MOSF w/Sepsis	ARF/MOSF	0	7	$25-$50k	9	57,345	null	null	32.666657	white	24	19	0.740967	0.660889	4	0	0	no	null	null	no dnr	15	81	10	62	22	36.39844	null	2.899902	0.599976	0.699951	134	null	168	4	2,800	null	0	adl>=4 (>=5 if sur)	0
5,584	25.95999	0	male	0	24	459	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	161,427	null	null	35	black	31.597656	51	0.774902	0.702881	14	0	0	no	null	null	no dnr	24	103	null	80	20	36.29688	null	3.099609	0.299988	0.899902	139	null	129	9	4,150	null	null	null	2.467773
5,585	59.53699	0	male	0	12	459	Colon Cancer	Cancer	1	18	null	0	32,064	null	null	15.5	white	16.898438	9	0.827881	0.625977	1	0	0	metastatic	null	null	no dnr	12	71	9.5	112	24	37.59375	null	3.699707	0.5	0.799927	142	null	80	6	null	null	0	no(M2 and SIP pres)	0
5,586	56.00299	1	female	0	25	266	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	0	170,509	null	null	19.75	white	29.5	66	0.662964	0.564941	43	0	0	no	0.5	0.2	dnr after sadm	1	110	6.599609	115	30	36.79688	330	3.799805	1.399902	0.899902	141	7.40918	403	20	2,300	null	3	no(M2 and SIP pres)	3
5,587	75.14899	1	male	0	5	9	Coma	Coma	2	null	null	44	28,049	null	null	22	white	17.597656	18	0.409973	0.335999	6	1	0	yes	0.5	0.1	dnr after sadm	3	94	1.5	118	32	35.5	null	2.599609	2.299805	0.399963	143	null	87	19	2,700	null	null	<2 mo. follow-up	2.07666
5,588	68.54797	0	female	0	20	457	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	0	91,794	null	null	29.666656	white	25	43	0.751953	0.67395	3	1	0	no	0.95	0.9	dnr after sadm	6	67	6.399414	82	20	36.69531	null	null	0.599976	1.399902	136	null	66	18	null	null	0	no(M2 and SIP pres)	0
5,589	37.12	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	$11-$25k	44	201,047	null	null	48	white	45.59375	93	0.140991	0.065994	30	0	0	no	null	null	dnr after sadm	5	125	5	105	12	38.79688	125	null	null	1.299805	150	7.429688	80	33	2,635	null	0	<2 mo. follow-up	0
5,590	62.66098	1	male	0	4	192	Lung Cancer	Cancer	2	15	>$50k	0	11,150	null	null	14	white	8.099609	12	0.849976	0.667969	1	0	0	metastatic	0.6	0.4	no dnr	4	95	14.699219	60	10	37	174.28125	null	0.699951	0.699951	130	7.589844	118	12	3,702	0	0	no(M2 and SIP pres)	0
5,591	60.54797	1	male	0	12	14	Coma	Coma	0	12	$11-$25k	44	49,329	null	null	38.5	white	25.699219	30	0.488953	0.416992	1	0	0	no	null	null	no dnr	12	102	12.398438	100	16	35.69531	376.1875	2.899902	0.399963	1.599854	142	7.419922	117	31	null	null	1	<2 mo. follow-up	1
5,592	38.66898	0	female	0	18	456	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	48,615	null	null	23	black	27.597656	33	0.840942	0.786987	1	0	0	no	0.9	0.9	no dnr	18	80	10.699219	120	24	38.19531	300	2.099609	null	0.699951	143	7.439453	123	18	860	0	1	no(M2 and SIP pres)	1
5,593	91.27698	1	female	0	6	95	COPD	COPD/CHF/Cirrhosis	2	12	null	0	6,053	null	null	12	white	17.296875	22	0.748901	0.603882	1	0	0	no	0.9	0.9	no dnr	6	107	7.299805	105	32	38.5	263.3125	2	null	0.699951	133	7.449219	343	17	4,880	null	1	adl>=4 (>=5 if sur)	1
5,594	60.93597	0	female	0	40	454	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	9	106,360	null	null	27.25	black	27.5	37	0.740967	0.659912	1	1	0	no	null	null	no dnr	40	100	5.599609	75	20	38	null	null	null	0.899902	140	null	97	6	2,450	null	1	no(M2 and SIP pres)	1
5,595	46.52399	1	female	1	10	10	MOSF w/Malig	ARF/MOSF	1	null	null	9	91,630	null	null	41	white	38.5	54	0.198975	0.106995	11	0	0	yes	0.6	0.2	dnr after sadm	9	133	5.899414	115	10	38.59375	145	null	1	1.199951	141	7.439453	94	15	2,290	null	null	<2 mo. follow-up	2.117676
5,596	77.80396	1	male	0	9	51	Cirrhosis	COPD/CHF/Cirrhosis	2	12	under $11k	0	9,589	null	null	10.5	white	19.597656	33	0.677979	0.507935	1	0	0	no	0.5	0.3	no dnr	9	115	13.599609	75	14	36.69531	511	null	null	0.899902	135	7.379883	131	20	1,100	null	0	<2 mo. follow-up	0
5,597	64.08197	1	female	1	148	148	ARF/MOSF w/Sepsis	ARF/MOSF	2	6	null	0	526,585	null	null	36.75	white	35	39	0.404968	0.28595	15	0	0	yes	0.75	0.7	dnr after sadm	35	128	13	115	8	36.39844	376.625	null	null	7.299805	136	7.299805	100	86	1,138	null	0	adl>=4 (>=5 if sur)	0
5,598	61.25897	1	male	0	7	70	Lung Cancer	Cancer	1	14	>$50k	0	6,386	null	null	5	white	13.898438	5	0.771973	0.526978	1	0	0	metastatic	0.6	0.1	no dnr	7	137	2.299805	120	24	38.09375	270	null	0.699951	0.599976	137	7.469727	121	13	5,250	null	0	null	0
5,599	72.25696	0	male	0	9	451	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	9	57,475	null	null	27.5	white	22.296875	48	0.748901	0.668945	4	0	0	no	0.88	0.85	no dnr	9	133	7.399414	75	28	37.5	null	null	null	1.899902	139	null	95	24	5,200	0	0	no(M2 and SIP pres)	0
5,600	74.23096	1	male	1	19	19	MOSF w/Malig	ARF/MOSF	1	16	>$50k	37	175,130	null	null	45	white	44	97	0.007999	0.001	42	0	0	yes	0.2	0.15	dnr after sadm	3	75	13.898438	65	13	36.5	344	3.399902	1.399902	8.199219	138	7.379883	193	66	0	null	0	<2 mo. follow-up	0

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.